CClinicalTrials.gg
Sign In
Status unknownNCT02961933USE AP OXUpdated Feb 11, 2020

Utah Study Evaluating Apneic Oxygenation for Emergency Department Intubation

An interventional study of Apneic oxygenation and Pre-oxgenation with NRB, NIPPV, BVM in Intubation, sponsored by Intermountain Health Care, Inc.. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-11.

Sponsored by Intermountain Health Care, Inc. · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Feb 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will determine rates of first pass success without hypoxemia in emergency department intubations with and without the use of apneic oxygenation by nasal cannula.

02

Conditions studied

  • Intubation

Browse trials for

Keywords

  • hypoxemia
  • intubation
  • apneic oxygenation
03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's planned enrollment of 500 is above the median of 145 across 931 interventional studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

Intermountain Health Care, Inc. is the lead sponsor of 118 studies on the registry; 15 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 3 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients requiring emergent Rapid Sequence or Delayed Sequence endotracheal intubation with administration of a neuromuscular blocker (Succinylcholine, Rocuronium)

Exclusion criteria

Exclusion Criteria:

  • Known prisoners
  • Patients in cardiac arrest
  • Patients who are intubated without the use of neuromuscular blockade (i.e., cardiac arrest, awake intubation).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    Apneic oxygenation

    Other: Apneic oxygenation

  • Active comparator
    non-apneic oxygenation

    Other: Pre-oxgenation with NRB, NIPPV, BVM

Interventions

  • OtherApneic oxygenation

    Nasal cannula apneic oxygenation

  • OtherPre-oxgenation with NRB, NIPPV, BVM

    Pre-oxygenation with non-rebreather mask, non-invasive positive pressure ventilation, or bag-valve mask

06

What researchers measure

Primary outcomes

  1. First pass success without hypoxemia

    Time frame: 10 minutes

Secondary outcomes

  1. Change in peri-intubation saturation

    Time frame: 0, 30, 60 and 120 seconds

  2. Saturation at time of tube placement

    Time frame: 10 minutes

  3. Time to desaturation <93%

    Time frame: measured time until saturations drop below 93% during the peri-intubation period, up to 10 minutes

  4. Saturation at post intubation

    Time frame: 0, 30, 60, and 120 seconds

07

Study locations

1 of 1 sites recruiting
  • Intermountain Medical Center
    Murray, Utah 84107, United States
    • Valerie Aston, MBA, RT · Contact · Valerie.Aston@imail.org · 801-507-4606
    • Rob Bryant, MD · Principal investigator
    • Joseph Bledsoe, MD · Sub investigator
    • Hill Stoecklein, MD · Sub investigator
    • Megan Fix, MD · Sub investigator
    • Amber Bledsoe, MD · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 11, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02961933
Lead sponsor
Intermountain Health Care, Inc.
Collaborators
University of Utah
Responsible party
Sponsor
First posted
Nov 11, 2016
Start date
Dec 2016
Primary completion
Jan 2020
Completion
Jun 2020 (estimated)
Last update
Feb 11, 2020

Study contacts

Valerie Aston, MBA, RT
Contact
valerie.aston@imail.org
801-507-4606
Robert Bryant, MD
principal investigator · Intermountain Health Care, Inc.

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Emergencies→

Other studies from this sponsor

Intermountain Health Care, Inc.

Start the discussion